{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:49Z","timestamp":1786984309175,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajo.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T19:29:15Z","timestamp":1563305355000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?"],"prefix":"10.1016","volume":"208","author":[{"given":"Daniela","family":"Eckstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline I.","family":"Riechardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-7376","authenticated-orcid":false,"given":"Jens","family":"Heufelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zeitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"B\u00f6ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brockmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2019.07.004_bib1","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.07.004_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2018.12.007","article-title":"Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy","volume":"131","author":"Li","year":"2019","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.ajo.2019.07.004_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-016-3429-4","article-title":"Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma","volume":"254","author":"Seibel","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2019.07.004_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/ceo.12927","article-title":"Risk factors for radiation-induced optic neuropathy: a case-control study","volume":"45","author":"Ferguson","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.004_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2017.03.027","article-title":"Adjuvant ab interno tumor treatment after proton beam irradiation","volume":"178","author":"Seibel","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2019.07.004_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.nima.2007.05.320","article-title":"Ion accelerator applications in medicine and cultural heritage","volume":"580","author":"Denker","year":"2007","journal-title":"Nucl Instrum Methods Phys Res A"},{"issue":"4","key":"10.1016\/j.ajo.2019.07.004_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2008-1034863","article-title":"Sehsch\u00e4rfenbestimmung nach europ\u00e4ischer Norm: wissenschaftliche Grundlagen und M\u00f6glichkeiten der automatischen Messung","volume":"212","author":"Bach","year":"1998","journal-title":"Klin Monbl Augenheilknd"},{"issue":"8","key":"10.1016\/j.ajo.2019.07.004_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ophtha.2009.12.015","article-title":"Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2019.07.004_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/ejo.5000670","article-title":"Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study","volume":"26","author":"Finger","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.004_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajo.2016.04.024","article-title":"Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma","volume":"168","author":"Seibel","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2019.07.004_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5301\/ejo.5000352","article-title":"Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma","volume":"24","author":"Mashayekhi","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.004_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000487543","article-title":"The use of intravitreal anti-VEGF and triamcinolone in the treatment of radiation papillopathy","volume":"4","author":"Roelofs","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ajo.2019.07.004_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00006982-200605000-00007","article-title":"Intravitreal triamcinolone for acute radiation papillopathy","volume":"26","author":"Shields","year":"2006","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2019.07.004_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajo.2006.09.014","article-title":"Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy","volume":"143","author":"Finger","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.07.004_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijrobp.2010.11.075","article-title":"Antivascular endothelial growth factor bevacizumab for radiation optic neuropathy: secondary to plaque radiotherapy","volume":"82","author":"Finger","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ajo.2019.07.004_bib16","first-page":"T2","article-title":"Ranibizumab for the prevention of radiation complications in patients treated with proton beam irradiation for choroidal melanoma (An American Ophthalmological Society thesis)","volume":"114","author":"Kim","year":"2016","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.ajo.2019.07.004_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","article-title":"Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma","volume":"121","author":"Shah","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2019.07.004_bib18","series-title":"AJCC Cancer Staging Manual","year":"2017"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419303277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419303277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:41:41Z","timestamp":1757598101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939419303277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":18,"alternative-id":["S0002939419303277"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2019.07.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}